Cervical cancer incidence in a prevaccine era in the United States, 1998-2002

被引:97
作者
Saraiya, Mona
Ahmed, Faruque
Krishnan, Sheila
Richards, Thomas B.
Unger, Elizabeth R.
Lawson, Herschel W.
机构
[1] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Atlanta, GA 30341 USA
[2] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA
[3] Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Atlanta, GA 30341 USA
关键词
D O I
10.1097/01.AOG.0000254165.92653.e8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To report the incidence of cervical cancer by geography, race or ethnicity, and histology. METHODS: We examined combined data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program covering 87% of the U.S. population. We calculated the age-adjusted incidence of cervical cancer by age, race or ethnicity, histology, and stage by region or state. RESULTS: Rates of invasive cancer per 100,000 females declined from 10.2 in 1998 to 8.5 in 2002. Incidence rates by state ranged from 6.6 to 12.3 per 100,000. Rates were especially high among Hispanic women aged 40 years or older (26.5 or more) and African -American women aged older than 50 years (23.5 or more). Rates of squamous cell carcinoma were significantly higher among African-American and Hispanic women than among their white counterparts. In contrast, rates of adenocarcinoma (18% of all cases) were significantly lower among African-American women than in white women (rate ratio 0.88, P<.05). Rates of adenocarcinorna were significantly higher among Hispanic women than among non-Hispanics (rate ratio 1.71, P<.05). Although no regional differences were noted for adenocarcinoma, rates of squamous cell carcinoma were higher in the South than in other regions. CONCLUSION: Despite intense screening in the past decade, higher rates of cervical cancer persist among women in the South and women who are African American or Hispanic. This information could guide more focused interventions to increase access to screening with cervical cytology as well as vaccination against human papillomavirus.
引用
收藏
页码:360 / 370
页数:11
相关论文
共 30 条
[1]  
Ahluwalia Indu B, 2003, MMWR Surveill Summ, V52, P1
[2]  
Berg JW, 1996, CANC EPIDEMIOLOGY PR, P28
[3]   Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors:: Implications for screening and prevention [J].
Castellsagué, X ;
Díaz, M ;
de Sanjosé, S ;
Muñoz, N ;
Herrero, R ;
Franceschi, S ;
Peeling, RW ;
Ashley, R ;
Smith, JS ;
Snijders, PJF ;
Meijer, CJLM ;
Bosch, FX .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (05) :303-315
[4]   Changes in cervical cancer incidence after three decades of screening US women less than 30 years old [J].
Chan, PG ;
Sung, HY ;
Sawaya, GF .
OBSTETRICS AND GYNECOLOGY, 2003, 102 (04) :765-773
[5]   Prevention of postoperative meatal stenosis with anteriorly and inferiorly based periosteal flaps in congenital aural atresia surgery [J].
Chang, SO ;
Jeon, SJ ;
Jeong, HS ;
Kim, CS .
OTOLOGY & NEUROTOLOGY, 2002, 23 (01) :25-28
[6]   Human papillomavirus types in invasive cervical cancer worldwide:: a meta-analysis [J].
Clifford, GM ;
Smith, JS ;
Plummer, M ;
Muñoz, N ;
Franceschi, S .
BRITISH JOURNAL OF CANCER, 2003, 88 (01) :63-73
[7]   Approximate confidence intervals for rate ratios from directly standardized rates with sparse data [J].
Fay, MP .
COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 1999, 28 (09) :2141-2160
[8]  
Fay MP, 1997, STAT MED, V16, P791
[9]   Variations in the age-specific curves of human papillomavirus prevalence in women worldwide [J].
Franceschi, Silvia ;
Herrero, Rolando ;
Clifford, Gary M. ;
Snijders, Peter J. F. ;
Arslan, Annie ;
Anh, Pham Thi Hoang ;
Bosch, F. Xavier ;
Ferreccio, Catterina ;
Hieu, Nguyen Trong ;
Lazcano-Ponce, Eduardo ;
Matos, Elena ;
Molano, Monica ;
Qiao, You-Lin ;
Rajkumar, Raj ;
Ronco, Guglielmo ;
de Sanjose, Silvia ;
Shin, Hai-Rim ;
Sukvirach, Sukhon ;
Thomas, Jaiye O. ;
Meijer, Chris J. L. M. ;
Munoz, Nubia .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (11) :2677-2684
[10]  
FREEMAN HP, 2005, 055282 NIH